Inventor

Michel Auguet

Inventor
Palaiseau, FR

Overview

21→
Patents
1992–2018
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes22%
C07CAcyclic or carbocyclic compounds7%
Y02ATechnologies for adaptation to climate change4%
C12YEnzymes2%
PatentTitleYear
9,918,967'Thiazole derivatives for treating dyskinesias caused by a chemical treatment'20189,259,458'Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy'20169,080,220'Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative'20159,006,274'Thiazole derivatives for treating dyskinesias caused by a chemical treatment'20158,921,322'Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus'20148,784,841'Therapeutic use of at least one botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy'20148,273,359'Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent'20127,345,066'Use of thiazole derivatives for preparing a medicine for protecting mitochondria'20087,285,664'Heterocyclic or benzenic derivatives of lipoic acid, their preparation and their use as medicaments'20076,936,715'Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines'20056,887,891'Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20056,872,738'Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance'20056,809,088'Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20046,630,461'Derivatives of 2-(iminomethyl) amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20036,605,637'Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them'20036,599,903'Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20036,586,454'Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20036,340,700'2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same'20026,335,445'Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them'20026,300,499'.alpha.1-adrenergic receptor antagonists'20015,081,148'Blocking agents of EDRF effect or formation for the treatment of shock'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2018Based in Palaiseau, FR· patent location history
2001–2008Patents assigned to SOD CONSEILS RECH APPLIC (12)· patent assignee history
2012–2018Patents assigned to IPSEN PHARMA SAS (7)· patent assignee history
2012–2015Patents assigned to AUGUET MICHEL (5)· patent assignee history
2012–2015Patents assigned to CHABRIER DE LASSAUNIERE PIERRE-ETIENNE (4)· patent assignee history
2012–2015Patents assigned to FAVRE CHRISTINE (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SOD CONSEILS RECH APPLIC122001–2008
IPSEN PHARMA SAS72012–2018
AUGUET MICHELself52012–2015
CHABRIER DE LASSAUNIERE PIERRE-ETIENNE42012–2015
FAVRE CHRISTINE42012–2015
Locations
LocationPatentsSpan
Palaiseau, FR211992–2018